Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Achilles Therapeutics Ltd.

achillestx.com

Latest From Achilles Therapeutics Ltd.

Achilles On Getting ‘New Wave’ Immunotherapy From Concept To Clinic In Three Years

Clonal neoantigen immunotherapy developer Achilles Therapeutics tells the Pink Sheet how the regulatory landscape for advanced therapies might not be as tricky as it used to be.

Research & Development Clinical Trials

Mentioned In Despatches: Ablynx's Story From The Frontline Of The Biotech Boom

A little over 12 months ago, Belgian Nanobody biotech Ablynx was at the center of a bidding war between Novo Nordisk and Sanofi. Ex-Ablynx CEO Edwin Moses talked to Scrip about the four-month period that changed the course of the company.

M & A Leadership

Venture Funding Deals: ADC Therapeutics, Unity Biotech Raise $100m-Plus

ADC Therapeutics and Unity Biotechnology close $100m-plus VC rounds, while Carrick comes close with a $95m debut. Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced in September and October 2016.

StartUps and SMEs Financing

Tech Transfer Roundup: How Johns Hopkins Optimizes Its Life Science Start-Ups

The Baltimore university relies on an extensive infrastructure for tech transfer, and has a high volume of output to show for it. Recent tech transfer deals include Spark, Spotlight, Achilles, Biohaven, Cantabio and Renova, Zucara and Heat Biologics.

Deals StartUps and SMEs
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
    • Pharmacogenetics-Pharmacogenomics
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Achilles Therapeutics Ltd.
  • Senior Management
  • Iraj Ali, PhD, CEO
    Jane Robertson, MD, CMO
    Dara Henry, PhD, VP, Operations & Bus. Dev.
    Robert Coutts, Dir., Fin.
  • Contact Info
  • Achilles Therapeutics Ltd.
    Phone: 1438 906 906
    Stevenage Bioscience Catalyst
    Gunnels Wood Rd
    Stevenage, SG1 2FX
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register